Red Cabbage Juice-Mediated Gut Microbiota Modulation Improves Intestinal Epithelial Homeostasis and Ameliorates Colitis

Emily Jean Wilson, Nagabhishek Sirpu Natesh, Parsa Ghadermazi, Ramesh Pothuraju, Dipakkumar R. Prajapati, Sanjit Pandey, Jussuf T. Kaifi, John R. Dodam, Jeffrey N. Bryan, Christian L. Lorson, Aude A. Watrelot, Jason M. Foster, Thomas J. Mansell, Siu Hung Joshua Chan, Surinder K. Batra, Jeyamkondan Subbiah, Satyanarayana RachaganiInternational Journal of Molecular Sciences 2023 · DOI

Abstract

Gut microbiota plays a crucial role in inflammatory bowel disease (IBD) and has therapeutic benefits. Thus, targeting the gut microbiota is a promising therapeutic approach for IBD treatment. We recently found that red cabbage juice (RCJ) ameliorates dextran sulfate sodium (DSS)-induced colitis in mice. However, the underlying mechanisms remain unknown. The current study investigated the modulation of gut microbiota in response to treatment with RCJ to ameliorate the DSS colitis. The initial results demonstrated that mice treated with DSS + RCJ showed increased body weight and decreased diarrhea and blood in feces compared to the DSS alone group. RCJ ameliorated colitis by regulating the intestinal barrier function by reducing the number of apoptotic cells, improving colonic protective mucin, and increasing tight junction protein in RCJ + DSS groups compared to the DSS group. Shotgun metagenomic analysis revealed significant enrichment of short-chain fatty acid (SCFAs)-producing bacteria (Butyrivibrio, Ruminococcaceae, Acetatifactor muris, Rosburia Sp. CAG:303, Dorea Sp. 5-2) increased PPAR-γ activation, leading to repression of the nuclear factor κB (NFκB) signaling pathway, thus decreasing the production of crucial inflammatory cytokines and chemokines in the RCJ + DSS groups compared to the DSS group. Pathway abundance analysis showed an increased abundance of the SCFA pathway, reduced histidine degradation (Bacteroides sartorii and Bacteroides caecimuris), and LCFA production in the RCJ+DSS treated group, suggesting the promotion of good colonic health. Furthermore, increased T-reg (FOXP3+) cells in the colon were due to SCFAs produced by the gut microbiota, which was corroborated by an increase in IL-10, a vital anti-inflammatory cytokine. Thus, our study provides the first evidence that RCJ ameliorates colonic inflammation by modulating the gut microbiota.

Introduction

Inflammatory Bowel Disease (IBD), encompassing ulcerative colitis and Crohn’s disease, is characterized by chronic gastrointestinal inflammation, epithelial barrier disruption, and microbial dysbiosis. While conventional therapies such as corticosteroids and biologics are available, their long-term use is often limited by significant side effects and the risk of secondary infections. Consequently, there is growing interest in dietary interventions and prebiotics that can modulate the gut microbiome to restore homeostasis.

Red cabbage juice (RCJ) is a nutrient-dense extract rich in anthocyanins and glucosinolates, traditionally used for its anti-inflammatory properties. While preliminary evidence suggested RCJ could alleviate colitis symptoms, the specific microbial and molecular mechanisms remained poorly understood. This study aimed to elucidate how RCJ influences the gut-microbiota-immune axis to protect against chemically induced colitis.

Methodology

Experimental Model and Treatment

The researchers utilized a standard Dextran Sulfate Sodium (DSS)-induced colitis model in C57BL/6J mice. RCJ was extracted using Pulsed Electric Field (PEF)-assisted technology to preserve bioactive compounds. Mice were administered RCJ via oral gavage for eight weeks, spanning the induction and recovery phases of DSS-induced inflammation.

Multi-Omic and Molecular Analysis

To achieve a high-resolution understanding of the microbial landscape, the team performed shotgun metagenomic sequencing on fecal samples (NCBI SRA: PRJNA944265). Functional profiling was conducted using the YAMP pipeline. Intestinal health was assessed through immunohistochemistry (IHC) for tight junction proteins (ZO-1, Occludin) and mucins (MUC2, MUC4). Apoptosis was quantified via TUNEL assay, while systemic and local inflammation were measured using cytokine arrays and oxidative stress markers (SOD, GPX4).

Results

Clinical and Histological Amelioration

RCJ treatment significantly improved clinical outcomes in mice subjected to DSS. Compared to the DSS-only group, RCJ-treated mice exhibited higher survival rates, reduced weight loss, and preserved colon length. Histologically, RCJ reduced the number of apoptotic cells in the colonic epithelium and restored the expression of critical barrier proteins, effectively mitigating the "leaky gut" phenotype associated with IBD.

Microbiome Reshaping and Functional Shifts

Shotgun metagenomics revealed that RCJ acts as a potent prebiotic, reversing the high Bacteroidetes-to-Firmicutes ratio seen in dysbiotic states. Specifically, RCJ enriched beneficial taxa including Butyrivibrio, Roseburia, and Acetatifactor muris. Functional analysis indicated a metabolic shift: RCJ treatment increased the abundance of pathways responsible for short-chain fatty acid (SCFA) production while reducing harmful histidine degradation and long-chain fatty acid (LCFA) synthesis.

Suppression of Inflammatory Signaling

The study identified a clear molecular cascade: the increase in microbial SCFAs activated Peroxisome Proliferator-Activated Receptor gamma (PPAR-γ). This activation subsequently repressed the Nuclear Factor kappa B (NFκB) pathway, the primary driver of pro-inflammatory cytokine production. Consequently, levels of TNF-α, IL-6, and IL-1β were significantly reduced in the RCJ + DSS group.

Immune Modulation and Oxidative Stress

RCJ treatment promoted the expansion of Foxp3+ T-regulatory (T-reg) cells in the colon. These cells are essential for maintaining immune tolerance and were associated with increased levels of the anti-inflammatory cytokine IL-10. Furthermore, RCJ restored antioxidant enzyme activity (SOD, GPX4) and suppressed oxidative damage markers like 4-OH-enol, indicating a reduction in local oxidative stress.

Discussion

The findings suggest that the therapeutic efficacy of RCJ in colitis is mediated by its ability to reprogram the gut's "local economy." By fostering SCFA-producing bacteria, RCJ provides the metabolites necessary to fuel colonocytes and signal the host immune system to dampen inflammation. The shift away from histidine degradation and LCFA production further suggests a transition toward a more stable and less inflammatory microbial environment.

However, RCJ is a complex mixture of polyphenols, oligosaccharides, and minerals. Identifying which specific bioactive component—or synergistic combination—is primarily responsible for these effects remains a challenge. Additionally, while the DSS mouse model is a robust proxy for human IBD, the complexity of the human microbiome necessitates further clinical validation.

Conclusion

This study provides the first comprehensive evidence that red cabbage juice ameliorates colonic inflammation by modulating the gut microbiota and activating the SCFA-PPAR-γ-NFκB axis. These results position RCJ as a promising prebiotic candidate for the management of IBD and highlight the potential of dietary interventions to restore intestinal homeostasis through microbial reprogramming.

Summary updated

Abstract

Gut microbiota plays a crucial role in inflammatory bowel diseases (IBD) and can potentially prevent IBD through microbial-derived metabolites, making it a promising therapeutic avenue. Recent evidence suggests that despite an unclear underlying mechanism, red cabbage juice (RCJ) alleviates Dextran Sodium Sulfate (DSS)-induced colitis in mice. Thus, the study aims to unravel the molecular mechanism by which RCJ modulates the gut microbiota to alleviate DSS-induced colitis in mice. Using C57BL/6J mice, we evaluated RCJ's protective role in DSS-induced colitis through two cycles of 3% DSS. Mice were daily gavaged with PBS or RCJ until the endpoint, and gut microbiota composition was analyzed via shotgun metagenomics. RCJ treatment significantly improved body weight (<i>p</i> ≤ 0.001), survival in mice (<i>p</i> < 0.001) and reduced disease activity index (DAI) scores. Further, RCJ improved colonic barrier integrity by enhancing the expression of protective colonic mucins (<i>p</i> < 0.001) and tight junction proteins (<i>p</i> ≤ 0.01) in RCJ + DSS-treated mice compared to the DSS group. Shotgun metagenomic analysis revealed an enrichment of short-chain fatty acids (SCFAs)-producing bacteria (<i>p</i> < 0.05), leading to increased Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) activation (<i>p</i> ≤ 0.001). This, in turn, resulted in repression of the nuclear factor κB (NFκB) signaling pathway, causing decreased production of inflammatory cytokines and chemokines. Our study demonstrates colitis remission in a DSS-induced mouse model, showcasing RCJ as a potential modulator for gut microbiota and metabolites, with promising implications for IBD prevention and treatment.
BibTeX
@article{wilson2023red,
  author = {Emily Jean Wilson and Nagabhishek Sirpu Natesh and Parsa Ghadermazi and Ramesh Pothuraju and Dipakkumar R. Prajapati and Sanjit Pandey and Jussuf T. Kaifi and John R. Dodam and Jeffrey N. Bryan and Christian L. Lorson and Aude A. Watrelot and Jason M. Foster and Thomas J. Mansell and Siu Hung Joshua Chan and Surinder K. Batra and Jeyamkondan Subbiah and Satyanarayana Rachagani},
  title = {{Red Cabbage Juice-Mediated Gut Microbiota Modulation Improves Intestinal Epithelial Homeostasis and Ameliorates Colitis}},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms25010539},
}
Figure